
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TP53 mutation, mitochondria and cancer
William M. Kamp, Pingyuan Wang, Paul M. Hwang
Current Opinion in Genetics & Development (2016) Vol. 38, pp. 16-22
Open Access | Times Cited: 58
William M. Kamp, Pingyuan Wang, Paul M. Hwang
Current Opinion in Genetics & Development (2016) Vol. 38, pp. 16-22
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer
Matthieu Lacroix, Romain Riscal, Giuseppe Arena, et al.
Molecular Metabolism (2019) Vol. 33, pp. 2-22
Open Access | Times Cited: 274
Matthieu Lacroix, Romain Riscal, Giuseppe Arena, et al.
Molecular Metabolism (2019) Vol. 33, pp. 2-22
Open Access | Times Cited: 274
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
Agnes Lee Chen Ong, Thamil Selvee Ramasamy
Ageing Research Reviews (2018) Vol. 43, pp. 64-80
Closed Access | Times Cited: 248
Agnes Lee Chen Ong, Thamil Selvee Ramasamy
Ageing Research Reviews (2018) Vol. 43, pp. 64-80
Closed Access | Times Cited: 248
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Nishant Gandhi, Gokul M. Das
Cells (2019) Vol. 8, Iss. 2, pp. 89-89
Open Access | Times Cited: 178
Nishant Gandhi, Gokul M. Das
Cells (2019) Vol. 8, Iss. 2, pp. 89-89
Open Access | Times Cited: 178
The Metabolic Mechanisms of Breast Cancer Metastasis
Lingling Wang, Shizhen Zhang, Xiaochen Wang
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 150
Lingling Wang, Shizhen Zhang, Xiaochen Wang
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 150
Colorectal Cancer and Metabolism
Rachel E. Brown, Sarah P. Short, Christopher S. Williams
Current Colorectal Cancer Reports (2018) Vol. 14, Iss. 6, pp. 226-241
Open Access | Times Cited: 100
Rachel E. Brown, Sarah P. Short, Christopher S. Williams
Current Colorectal Cancer Reports (2018) Vol. 14, Iss. 6, pp. 226-241
Open Access | Times Cited: 100
Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
Farzad Taghizadeh‐Hesary, Mohammad Houshyari, Mohammad Farhadi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6719-6741
Closed Access | Times Cited: 29
DNA polymerases in the mitochondria A critical review of the evidence
William C. Copeland
Frontiers in bioscience (2016) Vol. 22, Iss. 4, pp. 692-709
Open Access | Times Cited: 83
William C. Copeland
Frontiers in bioscience (2016) Vol. 22, Iss. 4, pp. 692-709
Open Access | Times Cited: 83
The Landscape of mtDNA Modifications in Cancer: A Tale of Two Cities
Kate L. Hertweck, Santanu Dasgupta
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 73
Kate L. Hertweck, Santanu Dasgupta
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 73
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression
Jinfang Zhang, Ming Chen, Yasheng Zhu, et al.
Developmental Cell (2018) Vol. 48, Iss. 3, pp. 329-344.e5
Open Access | Times Cited: 63
Jinfang Zhang, Ming Chen, Yasheng Zhu, et al.
Developmental Cell (2018) Vol. 48, Iss. 3, pp. 329-344.e5
Open Access | Times Cited: 63
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Rohan Wedam, Yoshimi Endo Greer, David Wisniewski, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1936-1936
Open Access | Times Cited: 21
Rohan Wedam, Yoshimi Endo Greer, David Wisniewski, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1936-1936
Open Access | Times Cited: 21
Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence
Martina Čižmáriková, Radka Michalková, Ladislav Mirossay, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1653-1653
Open Access | Times Cited: 20
Martina Čižmáriková, Radka Michalková, Ladislav Mirossay, et al.
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1653-1653
Open Access | Times Cited: 20
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution
Deepak Singhal, Li Yan A. Wee, Monika Kutyna, et al.
Leukemia (2019) Vol. 33, Iss. 12, pp. 2842-2853
Closed Access | Times Cited: 51
Deepak Singhal, Li Yan A. Wee, Monika Kutyna, et al.
Leukemia (2019) Vol. 33, Iss. 12, pp. 2842-2853
Closed Access | Times Cited: 51
Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome
Pingyuan Wang, Jie Li, Farzana L. Walcott, et al.
Journal of Clinical Investigation (2016) Vol. 127, Iss. 1, pp. 132-136
Open Access | Times Cited: 50
Pingyuan Wang, Jie Li, Farzana L. Walcott, et al.
Journal of Clinical Investigation (2016) Vol. 127, Iss. 1, pp. 132-136
Open Access | Times Cited: 50
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models
Massimo Moro, Daniela Di Paolo, Massimo Milione, et al.
Journal of Controlled Release (2019) Vol. 308, pp. 44-56
Open Access | Times Cited: 48
Massimo Moro, Daniela Di Paolo, Massimo Milione, et al.
Journal of Controlled Release (2019) Vol. 308, pp. 44-56
Open Access | Times Cited: 48
Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)–PDH kinase axis
Sun Mi Hong, Young‐Kyoung Lee, Imkyong Park, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 19, pp. 7810-7820
Open Access | Times Cited: 43
Sun Mi Hong, Young‐Kyoung Lee, Imkyong Park, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 19, pp. 7810-7820
Open Access | Times Cited: 43
Relationship between p53 status and the bioeffect of ionizing radiation (Review)
Xiaohan Kong, Dehai Yu, Zhaoyi Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 37
Xiaohan Kong, Dehai Yu, Zhaoyi Wang, et al.
Oncology Letters (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 37
Origin of Cancer: An Information, Energy, and Matter Disease
R. Hanselmann, Cornelius Welter
Frontiers in Cell and Developmental Biology (2016) Vol. 4
Open Access | Times Cited: 44
R. Hanselmann, Cornelius Welter
Frontiers in Cell and Developmental Biology (2016) Vol. 4
Open Access | Times Cited: 44
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations
Ildikó Krencz, Dániel Sztankovics, Titanilla Dankó, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 4, pp. 1141-1157
Open Access | Times Cited: 30
Ildikó Krencz, Dániel Sztankovics, Titanilla Dankó, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 4, pp. 1141-1157
Open Access | Times Cited: 30
Promotion of liquid-to-solid phase transition of cGAS by Baicalein suppresses lung tumorigenesis
Tiansheng Zheng, Haipeng Liu, Yifan Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Tiansheng Zheng, Haipeng Liu, Yifan Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds
Rituraj Chakraborty, Anupam Dutta, Rupak Mukhopadhyay
Clinical & Translational Oncology (2025)
Closed Access
Rituraj Chakraborty, Anupam Dutta, Rupak Mukhopadhyay
Clinical & Translational Oncology (2025)
Closed Access
Targeted OMA1 therapies for cancer
Marcel V. Alavi
International Journal of Cancer (2019) Vol. 145, Iss. 9, pp. 2330-2341
Open Access | Times Cited: 31
Marcel V. Alavi
International Journal of Cancer (2019) Vol. 145, Iss. 9, pp. 2330-2341
Open Access | Times Cited: 31
Ion channel mutations and cancer
Xinyu Cao, Liang Yan, Liang Hong
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101990-101990
Closed Access
Xinyu Cao, Liang Yan, Liang Hong
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101990-101990
Closed Access
Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy
Giuseppe Lonetto, Gabriela Koifman, Alon Silberman, et al.
Cell Death and Differentiation (2018) Vol. 26, Iss. 9, pp. 1566-1581
Open Access | Times Cited: 31
Giuseppe Lonetto, Gabriela Koifman, Alon Silberman, et al.
Cell Death and Differentiation (2018) Vol. 26, Iss. 9, pp. 1566-1581
Open Access | Times Cited: 31
Expression profile of E‐cadherin, estrogen receptors, and P53 in early‐onset gastric cancers
Fan Zhou, Yuanyuan Xu, Jiong Shi, et al.
Cancer Medicine (2016) Vol. 5, Iss. 12, pp. 3403-3411
Open Access | Times Cited: 28
Fan Zhou, Yuanyuan Xu, Jiong Shi, et al.
Cancer Medicine (2016) Vol. 5, Iss. 12, pp. 3403-3411
Open Access | Times Cited: 28
Network Pharmacology-Based Analysis on the Action Mechanism of Oleanolic Acid to Alleviate Osteoporosis
Yi Wu, Lijie Gao, Yingsai Fan, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 28410-28420
Open Access | Times Cited: 17
Yi Wu, Lijie Gao, Yingsai Fan, et al.
ACS Omega (2021) Vol. 6, Iss. 42, pp. 28410-28420
Open Access | Times Cited: 17